Lincoln Alternative Strategies LLC 13D/13G Filings for XORTX Therapeutics Inc. (XRTX)

Lincoln Alternative Strategies LLC 13D and 13G filings for XORTX Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-27
4:29 pm
Purchase
2025-10-2313GXORTX Therapeutics Inc.
XRTX
Lincoln Alternative Strategies LLC572,470
9.900%
572,470increase
(New Position)
Filing